Possible activation of effector B cells during drug‐induced hypersensitivity syndrome

Possible activation of effector B cells during drug‐induced hypersensitivity syndrome

Abstract Although the development of autoimmune disorders is recognized in drug‐induced hypersensitivity syndrome (DIHS), the serial change of B‐cell activity has not been well‐addressed. Herein, the serum levels of IL‐6, IL‐10, B‐cell activating factor of the tumor necrosis factor family (BAFF), an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yutaka Matsumura, Rei Watanabe, Yasuko Niijima, Haruka Kawakita, Junichi Furuta, Yoshiyuki Nakamura, Yosuke Ishitsuka, Naoko Okiyama, Yasuhiro Fujisawa, Manabu Fujimoto
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
APRIL
B cells
BAFF
cytokines
drug‐induced hypersensitivity syndrome
Dermatology
RL1-803
Immunologic diseases. Allergy
RC581-607
Acceso en línea:https://doaj.org/article/a195633fec104f5995783ac11eb0bd5b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/a195633fec104f5995783ac11eb0bd5b

Ejemplares similares